NDC 0074-1658 – Zemplar
Paricalcitol 5 ug/mL · Injection, Solution · Intravenous
Product NDC0074-1658
Product details
- Brand name
- Zemplar
- Generic name
- Paricalcitol
- Labeler
- AbbVie Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA020819
- Marketed since
- April 17, 1998
- Listing expires
- December 31, 2027
- Pharmacologic class
- Vitamin D Analog; Vitamin D2 Analog
Active ingredients
- Paricalcitol 5 ug/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0074-1658-01 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0074-1658-01) / 1 mL in 1 VIAL, SINGLE-DOSE | Apr 17, 1998 |
| 0074-1658-05 | 25 VIAL, MULTI-DOSE in 1 TRAY (0074-1658-05) / 2 mL in 1 VIAL, MULTI-DOSE | Apr 17, 1998 |
Recalls mentioning this NDC
- D-1388-2012 Jun 27, 2012 · Class II
CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.